{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:24:04Z","timestamp":1784035444671,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sodium selenite (SSE) has been reported to exert anti-tumor effects in several cancer cells. However, the underlying mechanisms in renal cancer are yet to be elucidated. The effects of SSE on the proliferation, metastasis, and apoptosis of renal cancer cells, as well as its mechanism, were investigated in this study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>ACHN and 786-O renal cancer cells were treated with different concentrations of SSE, MTT, and colony formation assays were used to detect the proliferation ability of cells. The migration of cells was detected using scratch-wound-healing and transwell-migration assays. The effect of SSE on apoptosis was assessed by AnnexinV-FITC\/PI double staining. Besides, Western blotting was employed to detect the protein-expression level and elucidate the underlying pathways. We also made subcutaneous xenografts in athymic mice to verify the effect of SSE on tumor growth in vivo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our results demonstrated that treatment with SSE resulted in significant inhibition of cell proliferation and migration. Flow cytometry and Western blot confirmed that SSE induced apoptosis via the endogenous apoptotic pathway. We also confirmed that SSE treatment causes an increase in intracellular reactive oxygen species (ROS) levels, resulting in the inhibition of nuclear transcription factor-\u03baB (NF-\u03baB) signaling. Modulation of the ROS level by the chemical inhibitor N-acetyl-cysteine reversed the effect of SSE on cells. Similarly, subcutaneous xenografts in athymic mice models showed that SSE inhibits tumor growth in vivo. <\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These results indicate that SSE inhibits proliferation and migration and induces apoptosis via ROS mediated inhibition of NF-\u03baB signaling in renal cancer cells.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-022-09965-8","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T16:03:31Z","timestamp":1660061011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Sodium selenite inhibits proliferation and metastasis through ROS\u2010mediated NF\u2010\u03baB signaling in renal cell carcinoma"],"prefix":"10.1186","volume":"22","author":[{"given":"Xiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenggang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"issue":"2","key":"9965_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"9965_CR2","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.juro.2009.12.035","volume":"183","author":"BC Leibovich","year":"2010","unstructured":"Leibovich BC, Lohse CM, Crispen PL, Boorjian SA, Thompson RH, Blute ML, Cheville JC. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol. 2010;183(4):1309\u201315.","journal-title":"J Urol"},{"issue":"1","key":"9965_CR3","doi-asserted-by":"publisher","first-page":"15698","DOI":"10.1038\/s41598-017-15922-4","volume":"7","author":"MCS Wong","year":"2017","unstructured":"Wong MCS, Goggins WB, Yip BHK, Fung FDH, Leung C, Fang Y, Wong SYS, Ng CF. Incidence and mortality of kidney cancer: temporal patterns and global trends in 39 countries. Sci Rep. 2017;7(1):15698.","journal-title":"Sci Rep"},{"issue":"3","key":"9965_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ctrv.2007.12.001","volume":"34","author":"K Gupta","year":"2008","unstructured":"Gupta K, Miller JD, Li JZ, Russell MW, Charbonneau C. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev. 2008;34(3):193\u2013205.","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"9965_CR5","doi-asserted-by":"publisher","first-page":"e170","DOI":"10.1016\/S1470-2045(13)70569-2","volume":"15","author":"G De Meerleer","year":"2014","unstructured":"De Meerleer G, Khoo V, Escudier B, Joniau S, Bossi A, Ost P, Briganti A, Fonteyne V, Van Vulpen M, Lumen N, et al. Radiotherapy for renal-cell carcinoma. Lancet Oncol. 2014;15(4):e170-177.","journal-title":"Lancet Oncol"},{"issue":"1","key":"9965_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9\u201329.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"9965_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/cncr.24713","volume":"116","author":"S Patil","year":"2010","unstructured":"Patil S, Ishill N, Deluca J, Motzer RJ. Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients: implications for clinical trial design and interpretation. Cancer. 2010;116(2):347\u201354.","journal-title":"Cancer"},{"key":"9965_CR8","doi-asserted-by":"crossref","unstructured":"Motzer RJ, Escudier B, Oudard S, Hutson TE, Porta C, Bracarda S, Grunwald V, Thompson JA, Figlin RA, Hollaender N, et al. Phase 3 trial of everolimus for metastatic renal cell carcinoma\u202f: final results and analysis of prognostic factors. Cancer. 2010;116(18):4256\u201365.","DOI":"10.1002\/cncr.25219"},{"issue":"6","key":"9965_CR9","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1200\/JCO.2009.23.9764","volume":"28","author":"CN Sternberg","year":"2010","unstructured":"Sternberg CN, Davis ID, Mardiak J, Szczylik C, Lee E, Wagstaff J, Barrios CH, Salman P, Gladkov OA, Kavina A, et al. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial. J Clin Oncol. 2010;28(6):1061\u20138.","journal-title":"J Clin Oncol"},{"issue":"4","key":"9965_CR10","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1079\/PNS2005467","volume":"64","author":"MP Rayman","year":"2005","unstructured":"Rayman MP. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc. 2005;64(4):527\u201342.","journal-title":"Proc Nutr Soc"},{"issue":"1","key":"9965_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1080\/07388550802658048","volume":"29","author":"GN Schrauzer","year":"2009","unstructured":"Schrauzer GN. Selenium and selenium-antagonistic elements in nutritional cancer prevention. Crit Rev Biotechnol. 2009;29(1):10\u20137.","journal-title":"Crit Rev Biotechnol"},{"issue":"4","key":"9965_CR12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3945\/jn.116.243279","volume":"147","author":"PD Terry","year":"2017","unstructured":"Terry PD, Qin B, Camacho F, Moorman PG, Alberg AJ, Barnholtz-Sloan JS, Bondy M, Cote ML, Funkhouser E, Guertin KA, et al. Supplemental Selenium May Decrease Ovarian Cancer Risk in African-American Women. J Nutr. 2017;147(4):621\u20137.","journal-title":"J Nutr"},{"issue":"8","key":"9965_CR13","doi-asserted-by":"publisher","first-page":"9649","DOI":"10.3390\/ijms13089649","volume":"13","author":"C Sanmartin","year":"2012","unstructured":"Sanmartin C, Plano D, Sharma AK, Palop JA. Selenium compounds, apoptosis and other types of cell death: an overview for cancer therapy. Int J Mol Sci. 2012;13(8):9649\u201372.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"9965_CR14","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.toxlet.2012.06.007","volume":"212","author":"SH Park","year":"2012","unstructured":"Park SH, Kim JH, Chi GY, Kim GY, Chang YC, Moon SK, Nam SW, Kim WJ, Yoo YH, Choi YH. Induction of apoptosis and autophagy by sodium selenite in A549 human lung carcinoma cells through generation of reactive oxygen species. Toxicol Lett. 2012;212(3):252\u201361.","journal-title":"Toxicol Lett"},{"issue":"1","key":"9965_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ijc.25029","volume":"127","author":"W Fang","year":"2010","unstructured":"Fang W, Han A, Bi X, Xiong B, Yang W. Tumor inhibition by sodium selenite is associated with activation of c-Jun NH2-terminal kinase 1 and suppression of beta-catenin signaling. Int J Cancer. 2010;127(1):32\u201342.","journal-title":"Int J Cancer"},{"issue":"5","key":"9965_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0302-2838(02)00400-1","volume":"42","author":"Z Dobrowolski","year":"2002","unstructured":"Dobrowolski Z, Drewniak T, Kwiatek W, Jakubik P. Trace elements distribution in renal cell carcinoma depending on stage of disease. Eur Urol. 2002;42(5):475\u201380.","journal-title":"Eur Urol"},{"issue":"3","key":"9965_CR17","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1002\/jcp.26783","volume":"234","author":"T Zhang","year":"2019","unstructured":"Zhang T, Zhao G, Zhu X, Jiang K, Wu H, Deng G, Qiu C. Sodium selenite induces apoptosis via ROS-mediated NF-\u03baB signaling and activation of the Bax-caspase-9-caspase-3 axis in 4T1 cells. J Cell Physiol. 2019;234(3):2511\u201322.","journal-title":"J Cell Physiol"},{"issue":"2","key":"9965_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"9965_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.clgc.2013.04.012","volume":"11","author":"MM Vickers","year":"2013","unstructured":"Vickers MM, Al-Harbi H, Choueiri TK, Kollmannsberger C, North S, MacKenzie M, Knox JJ, Rini BI, Heng DY. Prognostic factors of survival for patients with metastatic renal cell carcinoma with brain metastases treated with targeted therapy: results from the international metastatic renal cell carcinoma database consortium. Clin Genitourin Cancer. 2013;11(3):311\u20135.","journal-title":"Clin Genitourin Cancer"},{"issue":"2","key":"9965_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147(2):275\u201392.","journal-title":"Cell"},{"issue":"5","key":"9965_CR21","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871\u201390.","journal-title":"Cell"},{"issue":"34","key":"9965_CR22","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/onc.2010.215","volume":"29","author":"A Singh","year":"2010","unstructured":"Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010;29(34):4741\u201351.","journal-title":"Oncogene"},{"issue":"10","key":"9965_CR23","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.1002\/cam4.2403","volume":"8","author":"H Jiang","year":"2019","unstructured":"Jiang H, Shi QQ, Ge LY, Zhuang QF, Xue D, Xu HY, He XZ. Selenoprotein M stimulates the proliferative and metastatic capacities of renal cell carcinoma through activating the PI3K\/AKT\/mTOR pathway. Cancer Med. 2019;8(10):4836\u201344.","journal-title":"Cancer Med"},{"issue":"2","key":"9965_CR24","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3892\/ijo.2015.3041","volume":"47","author":"Y Gao","year":"2015","unstructured":"Gao Y, Guan Z, Chen J, Xie H, Yang Z, Fan J, Wang X, Li L. CXCL5\/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K\/AKT-induced upregulation of MMP2\/MMP9. Int J Oncol. 2015;47(2):690\u2013700.","journal-title":"Int J Oncol"},{"issue":"3","key":"9965_CR25","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1073\/pnas.1613855114","volume":"114","author":"F Bordeleau","year":"2017","unstructured":"Bordeleau F, Mason BN, Lollis EM, Mazzola M, Zanotelli MR, Somasegar S, Califano JP, Montague C, LaValley DJ, Huynh J, et al. Matrix stiffening promotes a tumor vasculature phenotype. Proc Natl Acad Sci U S A. 2017;114(3):492\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"9965_CR26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2174\/1570161115666170105124038","volume":"15","author":"KS Siveen","year":"2017","unstructured":"Siveen KS, Prabhu K, Krishnankutty R, Kuttikrishnan S, Tsakou M, Alali FQ, Dermime S, Mohammad RM, Uddin S. Vascular Endothelial Growth Factor (VEGF) Signaling in Tumour Vascularization: Potential and Challenges. Curr Vasc Pharmacol. 2017;15(4):339\u201351.","journal-title":"Curr Vasc Pharmacol"},{"issue":"5381","key":"9965_CR27","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1126\/science.281.5381.1305","volume":"281","author":"A Ashkenazi","year":"1998","unstructured":"Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science. 1998;281(5381):1305\u20138.","journal-title":"Science"},{"issue":"5","key":"9965_CR28","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ccr.2006.05.004","volume":"9","author":"DR Green","year":"2006","unstructured":"Green DR. At the gates of death. Cancer Cell. 2006;9(5):328\u201330.","journal-title":"Cancer Cell"},{"issue":"4 Suppl 5","key":"9965_CR29","first-page":"9","volume":"34","author":"JC Reed","year":"1997","unstructured":"Reed JC. Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Semin Hematol. 1997;34(4 Suppl 5):9\u201319.","journal-title":"Semin Hematol"},{"issue":"20","key":"9965_CR30","doi-asserted-by":"publisher","first-page":"7183","DOI":"10.1158\/0008-5472.CAN-04-1918","volume":"64","author":"AD Schimmer","year":"2004","unstructured":"Schimmer AD. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res. 2004;64(20):7183\u201390.","journal-title":"Cancer Res"},{"key":"9965_CR31","doi-asserted-by":"publisher","first-page":"109651","DOI":"10.1016\/j.cbi.2021.109651","volume":"349","author":"L Cao","year":"2021","unstructured":"Cao L, Zhang J, Du Y, Sun M, Xiang Y, Sheng Y, Ren X, Shao J. Selenite induced breast cancer MCF7 cells apoptosis through endoplasmic reticulum stress and oxidative stress pathway. Chem Biol Interact. 2021;349:109651.","journal-title":"Chem Biol Interact"},{"issue":"7","key":"9965_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17(7):395\u2013417.","journal-title":"Nat Rev Clin Oncol"},{"issue":"9\u201310","key":"9965_CR33","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s10495-021-01687-9","volume":"26","author":"S Das","year":"2021","unstructured":"Das S, Shukla N, Singh SS, Kushwaha S, Shrivastava R. Mechanism of interaction between autophagy and apoptosis in cancer. Apoptosis. 2021;26(9\u201310):512\u201333.","journal-title":"Apoptosis"},{"issue":"9","key":"9965_CR34","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1080\/15548627.2019.1695398","volume":"16","author":"HK An","year":"2020","unstructured":"An HK, Chung KM, Park H, Hong J, Gim JE, Choi H, Lee YW, Choi J, Mun JY, Yu SW. CASP9 (caspase 9) is essential for autophagosome maturation through regulation of mitochondrial homeostasis. Autophagy. 2020;16(9):1598\u2013617.","journal-title":"Autophagy"},{"issue":"2","key":"9965_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrc3204","volume":"12","author":"ND Perkins","year":"2012","unstructured":"Perkins ND. The diverse and complex roles of NF-kappaB subunits in cancer. Nat Rev Cancer. 2012;12(2):121\u201332.","journal-title":"Nat Rev Cancer"},{"issue":"21","key":"9965_CR36","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.2174\/0929867327666201111142307","volume":"28","author":"M Suhail","year":"2021","unstructured":"Suhail M, Tarique M, Muhammad N, Naz H, Hafeez A, Zughaibi TA, Kamal MA, Rehan M. A Critical Transcription Factor NF-\u03baB as a Cancer Therapeutic Target and its Inhibitors as Cancer Treatment Options. Curr Med Chem. 2021;28(21):4117\u201332.","journal-title":"Curr Med Chem"},{"issue":"56","key":"9965_CR37","doi-asserted-by":"publisher","first-page":"8961","DOI":"10.1038\/sj.onc.1207230","volume":"22","author":"J Kucharczak","year":"2003","unstructured":"Kucharczak J, Simmons MJ, Fan Y, Gelinas C. To be, or not to be: NF-kappaB is the answer\u2013role of Rel\/NF-kappaB in the regulation of apoptosis. Oncogene. 2003;22(56):8961\u201382.","journal-title":"Oncogene"},{"issue":"21","key":"9965_CR38","doi-asserted-by":"publisher","first-page":"12826","DOI":"10.1111\/jcmm.15874","volume":"24","author":"JF Liu","year":"2020","unstructured":"Liu JF, Chen PC, Chang TM, Hou CH. Thrombospondin-2 stimulates MMP-9 production and promotes osteosarcoma metastasis via the PLC, PKC, c-Src and NF-kappaB activation. J Cell Mol Med. 2020;24(21):12826\u201339.","journal-title":"J Cell Mol Med"},{"issue":"7","key":"9965_CR39","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1074\/jbc.M115.679704","volume":"291","author":"I Kastrati","year":"2016","unstructured":"Kastrati I, Siklos MI, Calderon-Gierszal EL, El-Shennawy L, Georgieva G, Thayer EN, Thatcher GR, Frasor J. Dimethyl Fumarate Inhibits the Nuclear Factor kappaB Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein. J Biol Chem. 2016;291(7):3639\u201347.","journal-title":"J Biol Chem"},{"issue":"1","key":"9965_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2010.178","volume":"21","author":"MJ Morgan","year":"2011","unstructured":"Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res. 2011;21(1):103\u201315.","journal-title":"Cell Res"},{"issue":"4","key":"9965_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/cells6040039","volume":"6","author":"M Kieliszek","year":"2017","unstructured":"Kieliszek M, Lipinski B, B\u0142a\u017cejak S. Application of Sodium Selenite in the Prevention and Treatment of Cancers. Cells. 2017;6(4):39.","journal-title":"Cells"},{"key":"9965_CR42","doi-asserted-by":"publisher","first-page":"668424","DOI":"10.3389\/fonc.2021.668424","volume":"11","author":"Z Cheng","year":"2021","unstructured":"Cheng Z, Yu S, He W, Li J, Xu T, Xue J, Shi P, Chen S, Li Y, Hong S, Xiao H. Selenite Induces Cell Cycle Arrest and Apoptosis via Reactive Oxygen Species-Dependent Inhibition of the AKT\/mTOR Pathway in Thyroid Cancer. Front Oncol. 2021;11:668424.","journal-title":"Front Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-09965-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-022-09965-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-09965-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T16:03:36Z","timestamp":1660061016000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-022-09965-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["9965"],"URL":"https:\/\/doi.org\/10.1186\/s12885-022-09965-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]},"assertion":[{"value":"9 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Committee for Research Ethics and for Animal Care and Use in Research, Nankai Hospital, Tianjin (China) approved the present study. We handled animals in compliance with the revised Animals (Scientific Procedures) Act 1986. This article adheres to the ARRIVE guidelines () for the reporting of animal experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"870"}}